New use for old drugs: Epirubicin in colorectal cancer
Acta Oncol
.
2021 Jul;60(7):954-956.
doi: 10.1080/0284186X.2021.1904519.
Epub 2021 Mar 30.
Authors
Line S Tarpgaard
1
,
Camilla Qvortrup
2
,
Signe L Nielsen
3
,
Jan Stenvang
3
,
Sönke Detlefsen
4
5
,
Nils Brünner
3
,
Per Pfeiffer
1
5
Affiliations
1
Department of Oncology, Odense University Hospital, Odense, Denmark.
2
Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
3
Faculty of Health and Medical Sciences, Institute of Drug Design and Pharmacology, University of Copenhagen, Frederiksberg, Denmark.
4
Department of Pathology, Odense University Hospital, Odense, Denmark.
5
Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
PMID:
33783307
DOI:
10.1080/0284186X.2021.1904519
No abstract available
Publication types
Letter
MeSH terms
Colonic Neoplasms*
Colorectal Neoplasms* / drug therapy
Epirubicin
Humans
Pharmaceutical Preparations*
Substances
Pharmaceutical Preparations
Epirubicin